Intactis Bio Corp.
PrivateLast Round
Grant
Jul 16, 2026
Total Funding Raised
$350,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Intactis Bio Corp. is a biotechnology and computing company that develops biohybrid processing units using 3D-printed living neural tissue for energy-efficient artificial intelligence and machine learning computation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Pharma Supply Chain
Business Model
B2B
Customer Profile
Usage-Based SaaS, Freemium
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intactis Bio Corp. Comparables
Compare Intactis Bio Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Biological Computing Co. | 45% | |
| PearCode | 37% | |
| Twist Bioscience Corporation | 35% |
Intactis Bio Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 16, 2026 | ||||
| Pre Seed | Mar 26, 2026 | ||||
| Seed | Sep 26, 2025 |
Key People
Founding team and executive leadership
Intactis Bio Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Utah Innovation Fund | Pre Seed |
| Shift Grants | Grant |
| Altitude Lab | Grant |
| rpv | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
Received grant funding from Altitude Lab, deepfunding, and others.
- Mar 26, 2026
$350K round with participation from rpv and Utah Innovation Fund.
Recent news
Latest coverage and updates
- launchesJul 21, 2026
Intactis launched Biostack Alpha on Jul 21st '26.
Intactis Bio Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Intactis Bio Corp.'s valuation, stock price, and market status.
Is Intactis Bio Corp. a public or private company?
Intactis Bio Corp. is a private company.
What is the current stock price of Intactis Bio Corp.?
Intactis Bio Corp. is a private company with no public stock price. Caplight tracks Intactis Bio Corp.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Intactis Bio Corp. worth (valuation)?
Valuation information for Intactis Bio Corp. is not publicly available.
Can I buy Intactis Bio Corp. stock?
Intactis Bio Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Intactis Bio Corp.'s last funding round?
Intactis Bio Corp.'s most recent funding round was Grant on July 16, 2026.
Who are the main investors in Intactis Bio Corp.?
Key investors in Intactis Bio Corp. include Utah Innovation Fund, Shift Grants, Altitude Lab, rpv.
Will Intactis Bio Corp. IPO soon?
No public IPO plans have been announced for Intactis Bio Corp..
How can I track Intactis Bio Corp. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Intactis Bio Corp.'s secondary market activity and sign up for updates.